Lv2
120 积分 2023-03-06 加入
The next generation of antibody–drug conjugates
12天前
已完结
The global epidemiology of acute myeloid leukaemia
26天前
已完结
Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer
26天前
已完结
Optimizing the safety of antibody–drug conjugates for patients with solid tumours
1个月前
已完结
Safety assessment of antibody-drug conjugates: Nonclinical toxicology, non-active ingredients, and environmental risk considerations
2个月前
已完结
Antibody-drug conjugate design and mechanisms of action for cancer treatment: state of the art and beyond
2个月前
已完结
Becotatug vedotin, MRG003, in previously treated recurrent or metastatic nasopharyngeal carcinoma: A multicenter, single-arm, phase IIa trial
4个月前
已完结
Esophageal Cancer: Overview, Risk Factors, and Reasons for the Rise
5个月前
已完结
皖公网安备34019202002308
